题目内容
Small, pink and very ugly. Hardly the qualities of a star, but they describe the deformed mouse that was the media darling at a recent science exhibition in Beijing. With a complex tissue structure in the shape of a human ear grafted on to its back, the rosy rodent was a stunning symbol of the serious strides China is making in the field of biotechnology.China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It’s establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.For the moment, the cooperation exists mostly with Europe and the U. S. But Asia’s other biotech leaders, Japan, Singapore and Korea, also are recognizing China’s potential as an attractive low-cost base to conduct research. These partnerships--and China’s advancement in the field of biotechnology--could help benefit the rest of Asia: China’s rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven’t met one scientist who believes they are being fully adhered to," says a European science analyst.If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China. As implied in the context, the shortcuts that might be taken include （）
查看答案
搜索结果不匹配？点我反馈
更多问题
阅读下面的文字，完成文后五题。人们对碳正离子进行研究时发现，它的“寿命”非常短，大约在10-23～10-6秒之间，因此，不能直接用仪器观测到这个有机反应中重要的中间体的“面目”。欧拉的贡献在于他发现了制备“长寿”高浓度碳正离子的方法。他采用了亲和能力小的溶剂，在低温(大约-100℃)下，可以使碳正离子具有长寿命。为了得到高浓度的碳正离子，欧拉使用一种很强的酸(被称为路易斯酸)，它可以使卤代烷生成碳正离子。欧拉的成就是建立在许多科学家辛勤工作的基础之上的。早在20世纪50年代，温斯坦在研究亲和取代反应和一些有机物重排时曾经假设，中间体碳正离子是非经典的，它包含一个5配位价的碳。1979年的诺贝尔化学奖获得者布朗对此也做过研究。但是这些仅是假设和解释而已。欧拉的大量工作证明了在强酸介质中，饱和碳氢化合物会发生质子化。通过对碳正离子的分析，能够发现低成本制造化工产品的方法，目前已有几十种产品得益于欧拉的发现。 欧拉的主要成就是指（）。
Que l’industrie (prendre) ______ exemple sur l’exploitation pétrolière de Daqing!
Small, pink and very ugly. Hardly the qualities of a star, but they describe the deformed mouse that was the media darling at a recent science exhibition in Beijing. With a complex tissue structure in the shape of a human ear grafted on to its back, the rosy rodent was a stunning symbol of the serious strides China is making in the field of biotechnology.China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It’s establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.For the moment, the cooperation exists mostly with Europe and the U. S. But Asia’s other biotech leaders, Japan, Singapore and Korea, also are recognizing China’s potential as an attractive low-cost base to conduct research. These partnerships--and China’s advancement in the field of biotechnology--could help benefit the rest of Asia: China’s rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven’t met one scientist who believes they are being fully adhered to," says a European science analyst.If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China. Science analysts are worried that China, in the course of biotech development, （）
Après (finir) _________ leurs devoirs, les étudiants sont allés au terrain de sport.
微信支付 
支付宝支付